Journal Health of Woman. 2026. 1(182): 5-9. doi: 10.15574/HW.2026.1(182).59

Feger O. V.¹, Pohoriliak R. Y.¹, Kaliy V. V.¹, Markovtsii L. Y.¹, Herasym L. M.^2
1Uzhhorod National University, Ukraine
²Bukovinian State Medical University, Chernivtsi, Ukraine

For citation: Feger OV, Pohoriliak RY, Kaliy VV, Markovtsii LY, Herasym LM. (2026). Trends and dynamics of HIV infection among the female population in 2016-2024. Ukrainian Journal Health of Woman. 1(182): 5-9. doi: 10.15574/HW.2026.1(182).59
Article received: Oct 24, 2025. Accepted for publication: Jan 28, 2026.

Human immunodeficiency virus (HIV) remains one of the leading medical and social problems of our time, characterized by the steady circulation of the pathogen and the uneven dynamics of morbidity among different population groups. Special attention is paid to the female population, in which the epidemic process has specific socio-biological features related to demographic, behavioral and availability of medical services, factors affecting the level of detection and spread of infection, as well as the effectiveness of preventive measures and early diagnosis, timely treatment, and control of the course of the disease.
Aim – to analyze the trends and dynamics of registered cases of HIV infection among the female population in Ukraine in 2016-2024.
Materials and methods. A retrospective descriptive epidemiological study was conducted based on official statistical data of the Public Health Center of the Ministry of Health of Ukraine. Methods of descriptive statistics, comparative and dynamic analysis with assessment of absolute indicators and rates of their changes in the temporal aspect were used.
Results. It was established that in the years 2016-2022, there was a tendency towards a gradual increase in the number of registered HIV cases among women from 62,576 to 72,714 cases, reaching a peak value in 2022. In 2019, a slight decrease in the indicator was noted, which may indicate a temporary stabilization of the epidemic process. In 2023, a slight decrease in the number of cases was recorded, while in 2024, there was a sharp decrease in the indicator to 62,968. The revealed dynamics have a wave-like character with periods of growth, stabilization, and decline.
Conclusions. The obtained results indicate the presence of an unstable epidemiological situation regarding HIV infection among the female population, with an upward trend in 2016-022 and a further sharp decrease in 2024. The identified changes can be due to both real shifts in the epidemic process and the influence of external social and organizational factors, which require further comprehensive analysis.
No conflict of interests was declared by the authors.
Keywords: human immunodeficiency virus (HIV), women, morbidity, dynamics, epidemiology.

REFERENCES

1. Atowoju I, Dawer P, Asrani M, Panjiyar B. (2024, Jul). Impact of maternal HIV infection on perinatal outcomes: A systematic review. Int J Gynaecol Obstet. 166(1): 35-43. https://doi.org/10.1002/ijgo.15528; PMid:38573155

2. De Waard L, Langenegger E, Erasmus K, Van der Merwe T, Olivier SE, Du Toit N et al. (2021, Dec 2). Maternal and neonatal outcomes of COVID-19 in a high-risk pregnant cohort with and without HIV. S Afr Med J. 111(12): 1174-1180. https://doi.org/10.7196/SAMJ.2021.v111i12.15683; PMid:34949304

3. Dude AM, Jones M, Wilson T. (2023, Jun). Human Immunodeficiency Virus in Pregnancy. Obstet Gynecol Clin North Am. 50(2): 389-399. https://doi.org/10.1016/j.ogc.2023.02.010; PMid:37149318

4. Feger OV, Pohoriliak RY, Kalii VV, Kozar OM. (2025). Dynamics of HIV prevalence among pregnant women in Ukraine in 2016-2024: regional analysis. Ukrainian Journal Health of Woman. 5(180): 21-26. https://doi.org/10.15574/HW.2025.5(180).2126; PMid:31489910

5. Gutema G, Tola HH, Fikadu D, Leta D, Bejiga B, Tura JB et al. (2023, Jun 6). Positivity rate, trend and associated risk factors of mother-to-child transmission of HIV among HIV-exposed infants. BMC Pediatr. 23(1): 283. https://doi.org/10.1186/s12887-023-04074-2; PMid:37280581 PMCid:PMC10245613

6. Karthigeyan KP, Binuya C, Vuong K, Permar SR, Nelson AN. (2024, Dec). Research on Maternal Vaccination for HIV Prevention. Clin Perinatol. 51(4): 769-782. https://doi.org/10.1016/j.clp.2024.08.007; PMid:39487019 PMCid:PMC11531644

7. Kumar N, Mangla M. (2022, Apr). 1Influence of paired pandemic of COVID-19 and HIV infection on pregnant women and children: A challenging issue. J Mother Child. 25(2): 123-126. doi: 10.34763/jmotherandchild.20212502.d-21-00017.

8. Lopes BB, Ramalho AKL, Oriá MOB, Cunha GHD, Aquino PS, Pinheiro AKB. (2023, Mar 27). Epidemiology of HIV in pregnant women and its relationship with the period of the COVID-19 pandemic. Rev Esc Enferm USP. 57: e20220339. https://doi.org/10.1590/1980-220x-reeusp-2022-0339en; PMid:36972324 PMCid:PMC10081587

9. Papadopoulos A, Thomas K, Protopapas K, Antonyak S, Begovac J, Dragovic G et al. (2023, Apr). HIV treatment strategies across Central, Eastern and Southeastern Europe: New times, old problems. HIV Med. 24(4): 462-470. https://doi.org/10.1111/hiv.13416; PMid:36196025

10. Ranzani A, Lapadula G, D'Aloia F, Ornaghi S, Locatelli A et al. (2025, Oct). Pregnancy in women living with HIV: Experience of IRCCS San Gerardo dei Tintori and a narrative review. New Microbiol. 48(3): 215-225.

11. Trindade LNM, Nogueira LMV, Rodrigues ILA, Guimarães RJPSE, Souza MHDN. (2023, Nov 20). Human immunodeficiency virus infection in pregnant women and its correlation with socioeconomic determinants. Rev Esc Enferm USP. 57: e20220321. https://doi.org/10.1590/1980-220x-reeusp-2022-0321en; PMid:37997877 PMCid:PMC10672042